Cost-analysis of opportunistic influenza vaccination in general medical inpatients

Daniel C Darmaputra; Farzana Y Zaman; Yin Li Khu; Vathy Nagalingam; Danny Liew; Ar Kar Aung

doi:10.1111/imj.15270

Cost-analysis of opportunistic influenza vaccination in general medical inpatients

Intern Med J. 2021 Apr;51(4):591-595. doi: 10.1111/imj.15270.

Authors

Daniel C Darmaputra^{1

2}, Farzana Y Zaman³, Yin Li Khu³, Vathy Nagalingam³, Danny Liew^{2

3}, Ar Kar Aung^{2

3}

Affiliations

¹ Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
² School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
³ Department of General Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.

PMID: 33890379
DOI: 10.1111/imj.15270

Abstract

Influenza vaccination is an important preventative health measure in the elderly and those with medical comorbidities. It has been shown to reduce hospitalisations, cardiovascular and respiratory complications. A significant proportion of patients admitted to general medicine are eligible for opportunistic inpatient influenza vaccination. This study explores the cost-effectiveness of such a strategy in reducing subsequent healthcare utilisation costs.

Keywords: cost-analysis; elderly; influenza; inpatient; vaccination.

MeSH terms

Aged
Cost-Benefit Analysis
Hospitalization
Humans
Influenza Vaccines*
Influenza, Human* / epidemiology
Influenza, Human* / prevention & control
Inpatients
Vaccination

Substances

Influenza Vaccines